DeutschNewstral
Article
Bbarrons.com on 2020-04-08 16:52
Sage Therapeutics Lays Off Staff to Save Cash After Failed Drug Trial
Related news
- BSage Therapeutics Is Cratering Because Its Depression Treatment Failed In A Key Trialbarrons.com
Does Sage Therapeutics' Failure Predict Its Future Results?Forbes- BSage Therapeutics Stock Collapsed Thursday. Analysts Say It Has Fallen Enough.barrons.com
- New Drug Eases Postpartum Depression In Victory For Tiny Sage TherapeuticsForbes
Five things you don’t know about Jeff Jonas, CEO of Sage Therapeuticsbizjournals.com
Sage Therapeutics surges on postpartum depression drug studyseattletimes.com- Sage Therapeutics sees modest results from tremor drug trialbizjournals.com
- Weed dispensary Sage Naturals changes name after lawsuit by Sage Therapeuticsbizjournals.com
- Top former Alnylam exec Barry Greene named CEO of Sage Therapeuticsbizjournals.com
- Sage Therapeutics Takes Investors On A Wild Ride As CEO Talks Up Brain DrugsForbes
- Sage Therapeutics to seek approval of postpartum depression drug after trial winbizjournals.com
- MSage Therapeutics stock bounces 49% after positive results for depression treatmentmarketwatch.com
- BHow Sage Therapeutics Beaten-Down Stock Could Come Back2 min readbarrons.com
- MSage Therapeutics shares surge 45% on positive trail of postpartum depression drugmarketwatch.com
- Promising drug by Sage Therapeutics helps treat post-partum depression in mid-stage trialbizjournals.com
- BNeurology Drug Study Does Little for Sage Therapeutics, or Its Partner Biogenbarrons.com
Mnuchin Lays Blame for Failed Trade Talks on ChinaThe New York Times
FDA Approves Sage Therapeutics’ Zulressowsj.com
Tango, Chat App Unicorn, Lays Off 9% Of Staff Following Failed Move Into E-CommerceTechCrunch